The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

without asthma, and those with severe asthma and past exacerbations faced a greater risk, according to data published in The Journal of Allergy and Clinical Immunology: In Practice. In this ...

Expert Rev Resp Med. 2012;6(6):629-638. Finally, another risk factor for asthma exacerbations is psychological issues, with stress (socioeconomic status, interpersonal conflicts, emotional ...

An estimated 136 million asthma exacerbations occur globally each year, 10 million of those in the US. Physically threatening and emotionally significant for patients, such exacerbations can be fatal.

amlitelimab was able to achieve a "clinically meaningful" reduction in asthma exacerbations at the medium dose tested, and a numerically greater reduction at the high dose, at week 60. The effect ...

May 22 (Reuters) - The U.S. Food and Drug Administration has approved British drugmaker GSK's (GSK.L), opens new tab asthma drug to ... had significantly reduced exacerbations by 21% compared ...

supplementation has been linked to fewer severe asthma exacerbations requiring hospitalization or oral steroids,” says Hendricks. Individual studies have found conflicting results, but overall ...

Roshni Naik, MD, allergist at Mount Sinai Health System, discusses the history of present illness for a case of severe asthma with nasal polyps: "Patient is a 45 year-old male with a past medical ...

In children and adults with established asthma, viral upper respiratory tract infections play a key role in producing acute exacerbations that may lead to healthcare utilization. Both ...

People who have experienced overlapping asthma exacerbation, persistent asthma, or asthma-chronic obstructive pulmonary disease (COPD) face elevated CVD morbidity and mortality risks. These risks ...

Asthma is a form of bronchial disorder caused by inflammation of the bronchi. It is characterized by spasmodic contraction of airway smooth muscle, difficulty breathing, wheezing and coughing ...

and more frequent asthma exacerbations. In the past five years, three monoclonal antibody therapies that target interleukin-5 or its receptor have been approved by the US Food and Drug ...